Exagen Inc., a California-based healthcare company, is making waves in the world of autoimmune disease testing with their AVISE brand. The company's unique cell-bound complement activation products technology enables healthcare providers to accurately diagnose, monitor, and treat autoimmune and autoimmune-related diseases such as systemic lupus erythematosus and rheumatoid arthritis. Exagen's flagship product, AVISE CTD, is designed to help physicians distinguish between connective tissue diseases and other conditions with similar symptoms. Exagen also offers AVISE Lupus, which measures activation of the complement system to quantify B-cell C4d and erythrocyte-bound C4d in a patient's blood, and AVISE APS, a panel of autoantibody tests to aid in the diagnosis and management of APS. Additionally, the company provides physicians with AVISE Vasculitis AAV, a testing panel assessing anti-neutrophil cytoplasmic antibody associated vasculitis, AVISE SLE Prognostic, a panel of autoantibodies used to assess potential complications affecting the kidney, brain, and cardiovascular system, and AVISE Anti-CarP test to identify RA patients with severe disease. Exagen's product lineup doesn't stop there, with AVISE PC4d for platelet-bound C4d measurement, and AVISE SLE Monitor, a biomarker blood test. AVISE MTX, a patented and validated blood test, along with AVISE HCQ, a blood test to monitor levels of hydroxychloroquine, round out the robust product offering. Exagen is also making strides in research, with a collaboration and license agreement with the Allegheny Health Network (AHN) Research Institute to explore novel patented biomarkers. This research could lead to breakthroughs in the treatment and management of autoimmune diseases. Formerly known as Exagen Diagnostics, Inc., the company changed its name to Exagen Inc. in January 2019. The company was incorporated in 2002 and is headquartered in Vista, California. Overall, Exagen's innovative technology and wide range of products are revolutionizing the way autoimmune diseases are diagnosed and managed.
Exagen's ticker is XGN
The company's shares trade on the NASDAQ stock exchange
They are based in Vista, California
There are 51-200 employees working at Exagen
It is exagen.com
Exagen is in the Healthcare sector
Exagen is in the Diagnostic Substances industry
The following five companies are Exagen's industry peers: